Jasper Therapeutics Inc - Asset Resilience Ratio

Latest as of March 2020: 53.37%

Jasper Therapeutics Inc (JSPR) has an Asset Resilience Ratio of 53.37% as of March 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Jasper Therapeutics Inc (JSPR) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$54.33 Million

Cash + Short-term Investments

Total Assets

$101.79 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Jasper Therapeutics Inc's Asset Resilience Ratio has changed over time. See JSPR total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jasper Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Jasper Therapeutics Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$54.33 Million	53.37%
Total Liquid Assets	$54.33 Million	53.37%

Asset Resilience Insights

Very High Liquidity: Jasper Therapeutics Inc maintains exceptional liquid asset reserves at 53.37% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jasper Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Jasper Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Jasper Therapeutics Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Jasper Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Jasper Therapeutics Inc

NASDAQ:JSPR USA Biotechnology

Market Cap

$26.03 Million

Market Cap Rank

#24197 Global

#4987 in USA

Share Price

$0.93

Change (1 day)

-0.64%

52-Week Range

$0.67 - $6.82

All Time High

$164.20